New York City, NY -- (SBWIRE) -- 12/09/2013 -- StockMarketIntel.com issues a special report on the following stocks: Liberator Medical Holdings, Inc. (NYSEMKT:LBMH), Advaxis, Inc. (OTCBB:ADXS), Advanced Cell Technology, Inc. (OTCMKTS:ACTC), Indo Global Exchange(s) PteLtd (OTCMKTS:IGEX)
Liberator Medical Holdings, Inc. (NYSEMKT:LBMH) added 3.33% recently, while trading on 43,241 shares, at the price of $3.75. The stock changed hands in a range of $3.65 to $3.77 up till now, bringing its market capitalization at about $196.41 million. If we look at its trading history of the past 52 weeks, the share price suffered a low of $0.67 and was moved to the maximum level of $4.20. Liberator Medical Holdings, Inc. is a national direct-to-consumer provider of medical supplies to Medicare-eligible seniors. The Company’s wholly owned subsidiary, Liberator Medical Supply, Inc. (LMS), is a direct-to-consumer, provider of Medicare Part B Benefits. LMS has four main product lines: diabetes, urological, ostomy and mastectomy.
Will LBMH Continue To Move Higher? Find Out Here
Advaxis, Inc. (OTCBB:ADXS) added 16.96% recently, in the current trading session, at $4.20 with a total volume of 899,845 shares. The stock, on average, trades on a volume of 232,586 shares. It floated in a range of $4.08 to $4.55 during the recent trading session, with a beta value of 1.05. Its market capitalization now moved to about $53.12 million. In the past 52 weeks, the share price has not declined below $2.60 or above $19.38. Advaxis, Inc. (Advaxis) is a development-stage company. The Company is a biotechnology company with the focus to develop immunotherapies for cancer and infectious diseases. These immunotherapies are based on a platform technology under license from the University of Pennsylvania (Penn), which utilizes live attenuated Listeria monocytogenes (Listeria or Lm) , bioengineered to secrete antigen/adjuvant fusion proteins.
Why Should Investors Buy ADXS After The Recent Gain? Just Go Here and Find Out
Advanced Cell Technology, Inc. (OTCMKTS:ACTC) recently recorded a fall of -0.82% and was moving within a range of $0.06-$0.06, its current trading price is $0.0605. The stock is moving up till now with a total volume of 884,512 shares, versus an average volume of 3.60 million shares. The share price hit its 52-week low of $0.05 and $0.10 was the best price. Advanced Cell Technology, Inc. is a biotechnology company focused on developing and commercializing human embryonic and adult stem cell technology in the emerging field of regenerative medicine. The Company has acquired, developed and maintained a portfolio of patents and patent applications that forms the base for its research and development efforts in the area of embryonic and adult stem cell research.
Has ACTC Found The Bottom And Ready To Gain Momentum? Find Out Here
Indo Global Exchange(s) PteLtd (OTCMKTS:IGEX) declined -10% in its current trading activity, bringing its market capitalization around $5.22 million. The share price, after opening at $0.07, hit a high of $0.07 and hovered above $0.07, while its recent trading price was $0.0720. The total number of shares changed hands during the current session up till now was 6,921 shares, as compared to average trading volume of 45,820 shares. Indo Global Exchange(s) Pte, Ltd., formerly Claridge Ventures, Inc., presents and provides online trading platforms. The Company’s online trading platforms offer market access to the clients, which include over 30 global equity exchanges for trading in securities; over 30 global equity exchanges for trading in contracts for differences (CFD's), which include Euro Zone, the United Kingdom, Japan, Asia, Oceania, Canada, & the United States; over 180 currency pairs in spot (Cash), forwards and options; gold and silver trading in spot (Cash), forwards and options; global commodity futures exchanges including financial futures, and indices and commodity CFD's.
Why Should Investors Buy IGEX After The Recent Gain? Just Go Here and Find Out
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)